Machine Learning Prediction of Cancer Cell Sensitivity to Drugs Based on Genomic and Chemical Properties
Michael P. Menden(Biotechnology Institute), Julio Sáez-Rodríguez(European Bioinformatics Institute), Ultan McDermott(AstraZeneca (United Kingdom)), Francesco Iorio(Human Technopole), Mathew J. Garnett(Wellcome Sanger Institute), Cyril H. Benes(Harvard University), Pedro J. Ballester(The London College)
Cited by 567
Related Papers
Mutations of the BRAF gene in human cancer
|Nature|2002|10.7k
Drug repurposing: progress, challenges and recommendations
|Nature Reviews Drug Discovery|2018|4.6k